• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. LIFESPAN EPTFE VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. LIFESPAN EPTFE VASCULAR GRAFT Back to Search Results
Catalog Number T07050C50
Device Problem Leak/Splash (1354)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/31/2024
Event Type  Injury  
Event Description
The distal end of the graft with the removed spiral support was anastomosed to the right common carotid artery.When the blood flow was released, bleeding from the graft occurred (area where the spiral support was removed).The doctor attempted to stop the bleeding with gauze, but it didn't stop.The bleeding area on the graft was sutured and adhesive was also applied to stop the bleeding.Since the bleeding from the graft surface was stopped, this graft was left in the blood vessel and the procedure was successfully completed.No other complications were reported to the patient.
 
Manufacturer Narrative
The unused portion of the device was returned for investigation.Inspection of the device found no sign of damage/abnormality that would cause leaking of the graft.The support spiral was able to be removed without any issues and did not cause any damage to the graft surface.It is possible the leakage occurred due to the process of anastomosing the graft to the artery during the procedure.Per the ifu: "when using a graft with removable external ptfe monofilament support, slowly unwind the monofilament at a right angle to the graft.Be careful to avoid removal of the thin spirally wrapped eptfe tape.Rapid unwinding and/or removal of the monofilament support parallel to the axis of the graft may damage the product.Suture technique: disruption of the graft, host vessel, and/or suture lines may occur if appropriate suture techniques are not observed.Utilize a small diameter, tapered, non-cutting needle to prevent bleeding from suture holes." we have conducted a lot history review and did not find any issues noted in the manufacturing or packaging process that could be related to this issue.All qc tests passed their requirements.Further, we have not received any other complaints of a similar nature for devices from this lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESPAN EPTFE VASCULAR GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer Contact
peter song
63 second ave
burlington, MA 01803
7814251683
MDR Report Key18817602
MDR Text Key336741114
Report Number1220948-2024-00057
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K130016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberT07050C50
Device Lot NumberLVG3493A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/15/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2024
Initial Date FDA Received03/01/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-